2016

10782 bookmarks
Newest
Effect of processed aloe vera gel on immunogenicity in inactivated quadrivalent influenza vaccine and upper respiratory tract infection in healthy adults A randomized double-blind placebo
Effect of processed aloe vera gel on immunogenicity in inactivated quadrivalent influenza vaccine and upper respiratory tract infection in healthy adults A randomized double-blind placebo
Aloe vera is a functional food with various pharmacological functions, including an immune-modulating effect. Until now, A. vera has never been studie…
·sciencedirect.com·
Effect of processed aloe vera gel on immunogenicity in inactivated quadrivalent influenza vaccine and upper respiratory tract infection in healthy adults A randomized double-blind placebo
Barrett's esophagus
Barrett's esophagus
The human intestinal microbiome is thought to influence tumor development and progression in the gastrointestinal tract by various mechanisms. Therefore, by better understanding the microbiome in eso...
·onlinelibrary.wiley.com·
Barrett's esophagus
Medical Train Wreck
Medical Train Wreck
Vaccine doomsday is what we have, and even if the CDC reduces the death numbers by half, which they just secretly did, we have an incredibly sick story. So many death by lethal injection. A flood of vaccine deaths and severe injuries. A river of tears. Congratulations to the doctors, nurses, and health officials who... View Article
·drsircus.com·
Medical Train Wreck
France Warned US in 2015 About Wuhan Lab It Helped Build, Former COVID-19 Investigator Claims
France Warned US in 2015 About Wuhan Lab It Helped Build, Former COVID-19 Investigator Claims
The U.S. federal government should have stopped funding research at the Wuhan Institute of Virology in 2015 when China reduced its cooperation with the French in building and operating the lab, according to the leader of an investigation into COVID-19’s origins by the State Department under the Trump administration.
·theepochtimes.com·
France Warned US in 2015 About Wuhan Lab It Helped Build, Former COVID-19 Investigator Claims
Pfizer Projects $33 Billion in COVID Vaccine Revenues, Driven by Boosters and Vaccines for Kids • Children's Health Defense
Pfizer Projects $33 Billion in COVID Vaccine Revenues, Driven by Boosters and Vaccines for Kids • Children's Health Defense
Pfizer hiked its projections for COVID vaccine revenues, telling investors this week it expects booster shots, a vaccine targeting the Delta variant and anticipated authorization of its vaccines for children as young as 6 months will drive revenues higher.
·childrenshealthdefense.org·
Pfizer Projects $33 Billion in COVID Vaccine Revenues, Driven by Boosters and Vaccines for Kids • Children's Health Defense
ICAN RESPONDS TO THE DOJ’S INCORRECT CONCLUSION THAT AN EMERGENCY USE VACCINE CAN BE MANDATED ICAN - Informed Consent Action Network
ICAN RESPONDS TO THE DOJ’S INCORRECT CONCLUSION THAT AN EMERGENCY USE VACCINE CAN BE MANDATED ICAN - Informed Consent Action Network
Since the three COVID-19 vaccines were granted emergency use authorization (EUA) in the U.S., the question of whether employers, schools, and others can mandate the vaccines has been heavily debated.  […]
·icandecide.org·
ICAN RESPONDS TO THE DOJ’S INCORRECT CONCLUSION THAT AN EMERGENCY USE VACCINE CAN BE MANDATED ICAN - Informed Consent Action Network
Doctor explains how Alzheimer's Reversal is Real-with Dr.Bredesen The Empowering Neurologist EP130 - YouTube
Doctor explains how Alzheimer's Reversal is Real-with Dr.Bredesen The Empowering Neurologist EP130 - YouTube
Most everyone knows of a cancer survivor. But, by and large, when a person receives a diagnosis of Alzheimer's disease, it is often assumed that this is an indication of an almost certain outcome. Alzheimer's disease is not caused by a specific flaw. While energy deficiency, inflammation, infectious agents, beta amyloid, acetylcholine deficiency, trauma, toxins, metabolic issues, and genetics are all worthy of consideration, it is clearly myopic to consider that targeting one of these popular ideas is going to solve the problem. It doesn’t. Our guest today has taken a different approach. Rather than trying to find a unique drug or technique that can help the Alzheimer's population at large, this novel approach focuses on identifying how variations in multiple parameters can be targeted with the overall goal of improving brain functionality that is compromised in the developing Alzheimer's situation. This approach, a personalized medicine approach, directly challenges the notion of a one-size-fits-all mentality as it relates to treating medical problems. And to be sure, Dr. Bredesen is demonstrating incredible success not just in stabilizing Alzheimer's patients but actually in bringing about their improvement. This is revolutionary, and I urge you to pay close attention to his message today. ==== Dr. Bredesen received his undergraduate degree from Caltech and his medical degree from Duke. He served as Resident and Chief Resident in Neurology at UCSF, then was postdoctoral fellow in the laboratory of Nobel laureate Prof. Stanley Prusiner. He was a faculty member at UCLA from 1989-1994, then was recruited by the Burnham Institute to direct the Program on Aging. In 1998 he became the Founding President and CEO of the Buck Institute for Research on Aging, and Adjunct Professor at UCSF; then in 2013 he returned to UCLA as the Director of the Easton Center for Alzheimer’s Disease Research. The Bredesen Laboratory studies basic mechanisms underlying the neurodegenerative process, and the translation of this knowledge into effective therapeutics for Alzheimer’s disease and other neurodegenerative conditions, leading to the publication of over 220 research papers. He established the ADDN (Alzheimer’s Drug Development Network) with Dr. Varghese John in 2008, leading to the identification of new classes of therapeutics for Alzheimer’s disease. He and his group developed a new approach to the treatment of Alzheimer’s disease, and this approach led to the discovery of subtypes of Alzheimer’s disease, followed by the first description of reversal of symptoms in patients with MCI and Alzheimer’s disease, with the ReCODE (reversal of cognitive decline) protocol, published in 2014, 2016, and 2018. Dr. Bredesen is the author of the New York Times bestseller, The End of Alzheimer’s, and the newly released, The End of Alzheimer’s Program. His newest book, The First Survivors of Alzheimer’s, chronicles how this program has virtually rewritten the lives of so many, and reveals, from the patient’s perspective, what this has meant. Here’s a link to his latest research paper showing improvement in an astounding 80% of Alzheimer’s patients: https://www.drperlmutter.com/study/precision-medicine-approach-alzheimers-disease-successful-proof-concept-trial/ Twitter @DrDaleBredesen FB @drdalebredesen IG @drdalebredesen ___________________________ Instagram: https://www.instagram.com/davidperlmutter/ Website: https://www.drperlmutter.com/ Subscribe to our channel: https://www.youtube.com/channel/UCDRl_UAXxbHyOOjklnA0dxQ/?sub_confirmation=1
·youtube.com·
Doctor explains how Alzheimer's Reversal is Real-with Dr.Bredesen The Empowering Neurologist EP130 - YouTube
Helpful Tips For Healing A Gluten-Ravaged Body GreenMedInfo Blog
Helpful Tips For Healing A Gluten-Ravaged Body GreenMedInfo Blog
Many of us ate wheat and gluten-containing products from infanthood into adulthood, unaware of the many adverse health effects that came with this socially–sanctioned dietary practice, until our bodies forced us to fully appreciate the darker side of wheat. Now, having thrust a baguette into the glutinous heart of the wheat monster, many of us have bodies that are still recovering from its ravages.
·greenmedinfo.com·
Helpful Tips For Healing A Gluten-Ravaged Body GreenMedInfo Blog
! Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues PNAS
! Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues PNAS
An unresolved issue of SARS-CoV-2 disease is that patients often remain positive for viral RNA as detected by PCR many weeks after the initial infection in the absence of evidence for viral replication. We show here that SARS-CoV-2 RNA can be reverse-transcribed and integrated into the genome of the infected cell and be expressed as chimeric transcripts fusing viral with cellular sequences. Importantly, such chimeric transcripts are detected in patient-derived tissues. Our data suggest that, in some patient tissues, the majority of all viral transcripts are derived from integrated sequences. Our data provide an insight into the consequence of SARS-CoV-2 infections that may help to explain why patients can continue to produce viral RNA after recovery. All data supporting the findings of this study are available within the article and supporting information. All sequencing data generated in this study have been deposited to the Sequence Read Archive, (accession no. [PRJNA721333][1]). All published data analyzed in this study are cited in this article with accession methods provided in [ Materials and Methods ][2]. July 14, 2021: The SI appendix has been updated. [1]: https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA721333 [2]: #sec-5
·pnas.org·
! Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues PNAS